Serum indices: managing assay interference

Clinical laboratories frequently encounter samples showing significant haemolysis, icterus or lipaemia. Technical advances, utilizing spectrophotometric measurements on automated chemistry analysers, allow rapid and accurate identification of such samples. However, accurate quantification of haemolysis, icterus and lipaemia interference is of limited value if laboratories do not set rational alert limits, based on sound interference testing experiments. Furthermore, in the context of increasing consolidation of laboratories and the formation of laboratory networks, there is an increasing requirement for harmonization of the handling of haemolysis, icterus and lipaemia-affected samples across different analytical platforms. Harmonization may be best achieved by considering both the analytical aspects of index measurement and the possible variations in the effects of haemolysis, icterus and lipaemia interferences on assays from different manufacturers. Initial verification studies, followed up with ongoing quality control testing, can help a laboratory ensure the accuracy of haemolysis, icterus and lipaemia index results, as well as assist in managing any biases in index results from analysers from different manufacturers. Similarities, and variations, in the effect of haemolysis, icterus and lipaemia interference in assays from different manufacturers can often be predicted from the mechanism of interference. Nevertheless, interference testing is required to confirm expected similarities or to quantify differences. It is important that laboratories are familiar with a number of interference testing protocols and the particular strengths and weaknesses of each. A rigorous approach to all aspects of haemolysis, icterus and lipaemia interference testing allows the analytical progress in index measurement to be translated into improved patient care.

[1]  Mario Plebani,et al.  Performance criteria and quality indicators for the pre-analytical phase , 2015, Clinical chemistry and laboratory medicine.

[2]  Mauro Panteghini,et al.  Harmonization of automated hemolysis index assessment and use: Is it possible? , 2014, Clinica chimica acta; international journal of clinical chemistry.

[3]  Nora Nikolac,et al.  Lipemia: causes, interference mechanisms, detection and management , 2014, Biochemia medica.

[4]  Steven W. Cotten,et al.  Cyclodextrin removal of lipemic interference: an attractive alternative to ultracentrifugation for satellite laboratories. , 2013, Archives of pathology & laboratory medicine.

[5]  D. Stevenson,et al.  The effect of hematocrit on the efficacy of phototherapy for neonatal jaundice , 2013, Pediatric Research.

[6]  C. McCudden,et al.  Endogenous Interferences in Clinical Laboratory Tests: Icteric, Lipemic and Turbid Samples , 2012 .

[7]  M. Gorenjak,et al.  Investigation of unusual high serum indices for lipemia in clear serum samples on Siemens analysers Dimension , 2012, Biochemia medica.

[8]  Potassium but not lactate dehydrogenase elevation due to in vitro hemolysis is higher in capillary than in venous blood samples. , 2012, Archives of pathology & laboratory medicine.

[9]  E. Kearney,et al.  Effect of Patent Blue V® dye on sample interference indices on the Abbott Architect , 2012, Annals of clinical biochemistry.

[10]  James H Derzon,et al.  Effectiveness of practices to reduce blood sample hemolysis in EDs: a laboratory medicine best practices systematic review and meta-analysis. , 2012, Clinical biochemistry.

[11]  L. Flors,et al.  Diagnostic accuracy of icteric index to detect abnormal total bilirubin values , 2012, Journal of Clinical Pathology.

[12]  F. Petrat,et al.  Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome , 2012, Critical Care.

[13]  G. Lippi,et al.  Hemolysis, lipaemia and icterus in specimens for arterial blood gas analysis. , 2012, Clinical biochemistry.

[14]  G. Lippi,et al.  Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. , 2012, European journal of internal medicine.

[15]  O. Baskurt.  Red Blood Cell Mechanical Stability , 2012 .

[16]  J. D. Berg,et al.  Variation in phlebotomy techniques in emergency medicine and the incidence of haemolysed samples , 2011, Annals of clinical biochemistry.

[17]  P. Calmarza,et al.  Lipemia interferences in routine clinical biochemical tests. , 2011, Biochemia medica.

[18]  A. Seltsam,et al.  Menopausal status affects the susceptibility of stored RBCs to mechanical stress , 2011, Vox sanguinis.

[19]  A. Atay,et al.  Effects of hemolysis interferences on routine biochemistry parameters. , 2011, Biochemia medica.

[20]  A. Verstraete,et al.  An unusual case of (pseudo)hypertriglyceridaemia , 2010, NDT plus.

[21]  C. Florkowski,et al.  The effect of hemolysis on current troponin assays--a confounding preanalytical variable? , 2010, Clinical chemistry.

[22]  Ranjna Chawla,et al.  Identification of the Types of Preanalytical Errors in the Clinical Chemistry Laboratory: 1-Year Study at G.B. Pant Hospital , 2010 .

[23]  J. Söderberg,et al.  Haemolysis index – an estimate of preanalytical quality in primary health care , 2009, Clinical chemistry and laboratory medicine.

[24]  R. Beetham,et al.  A monoclonal protein identified by an anomalous lipaemia index , 2009, Annals of clinical biochemistry.

[25]  Mario Plebani,et al.  Multicenter evaluation of the hemolysis index in automated clinical chemistry systems , 2009, Clinical chemistry and laboratory medicine.

[26]  J. Nicastro,et al.  A retrospective analysis of the incidence of hemolysis in type and screen specimens from trauma patients. , 2009, The International journal of angiology : official publication of the International College of Angiology, Inc.

[27]  A. Šimundić,et al.  Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? , 2009, Clinical chemistry and laboratory medicine.

[28]  Yiduo Wu.  Interference from Rose Bengal with Total Bilirubin Measurement , 2009 .

[29]  Mario Plebani,et al.  Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories , 2008, Clinical chemistry and laboratory medicine.

[30]  D. Darby,et al.  Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V , 2008, Annals of clinical biochemistry.

[31]  P. Carraro.  Potassium report of hemolyzed serum samples , 2008, Clinical chemistry and laboratory medicine.

[32]  J. Eckfeldt,et al.  Measurements of Free Hemoglobin and Hemolysis Index: EDTA- or Lithium-Heparinate Plasma? , 2007 .

[33]  M. Peake,et al.  Measurement of serum creatinine--current status and future goals. , 2006, The Clinical biochemist. Reviews.

[34]  D. Baer,et al.  Investigating elevated potassium values. , 2006, MLO: medical laboratory observer.

[35]  G. Lippi,et al.  Influence of hemolysis on routine clinical chemistry testing , 2006, Clinical chemistry and laboratory medicine.

[36]  A. Shenkin,et al.  Mechanism of interference by haemolysis in the cardiac troponin T immunoassay , 2006, Annals of clinical biochemistry.

[37]  J. Delanghe,et al.  Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism , 2006, Clinical chemistry and laboratory medicine.

[38]  G. Dimeski,et al.  Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system. , 2006, Clinical chemistry.

[39]  K. Speroni,et al.  Factors affecting hemolysis rates in blood samples drawn from newly placed IV sites in the emergency department. , 2005, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[40]  R. F. Roberts,et al.  Assay-specific differences in lipemic interference in native and intralipid-supplemented samples. , 2004, Clinical chemistry.

[41]  M. Kroll.  Evaluating interference caused by lipemia. , 2004, Clinical chemistry.

[42]  C. Fraser.  Test result variation and the quality of evidence-based clinical guidelines. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[43]  G. Dimeski.  Effects of hemolysis on the Roche ammonia method for Hitachi analyzers. , 2004, Clinical chemistry.

[44]  P. Twomey,et al.  Unreliability of triglyceride measurement to predict turbidity induced interference , 2003, Journal of clinical pathology.

[45]  L. Pantanowitz,et al.  Artifactual hyperbilirubinemia due to paraprotein interference. , 2003, Archives of pathology & laboratory medicine.

[46]  K. Sztefko,et al.  [Interferences in immunoassay]. , 2012, Przeglad lekarski.

[47]  N. Yoshikawa,et al.  Hemolysis in Serum Samples Drawn by Emergency Department Personnel versus Laboratory Phlebotomists , 2002 .

[48]  Callum G. Fraser,et al.  Biological Variation: From Principles to Practice , 2001 .

[49]  M. Kroll,et al.  Mechanism of interference of a polymerized hemoglobin blood substitute in an alkaline phosphatase method. , 2000, Clinical chemistry.

[50]  M Plebani,et al.  Hemolyzed specimens: a reason for rejection or a clinical challenge? , 2000, Clinical chemistry.

[51]  F. Trivin,et al.  Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA. , 1998, Clinical chemistry.

[52]  P. L. Reddy,et al.  Binding of nitric oxide to thiols and hemes in hemoglobin H: implications for alpha-thalassemia and hypertension. , 1997, Clinical chemistry.

[53]  G. Hortin,et al.  Lipemia interference with a rate-blanked creatinine method. , 1997, Clinical chemistry.

[54]  D Grafmeyer,et al.  The Influence of Bilirubin, Haemolysis and Turbidity on 20 Analytical Tests Performed on Automatic Analysers , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[55]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.

[56]  K. Whalen,et al.  Conjugated, but not unconjugated, bilirubin negatively interferes in Hitachi 747 assay of inorganic phosphorus. , 1993, Clinical chemistry.

[57]  P. Duggan,et al.  A simplified procedure for eliminating the negative interference of bilirubin in the Jaffé reaction for creatinine. , 1992, Clinical chemistry.

[58]  C G Fraser,et al.  Analytical Goals for Interference , 1991, Annals of clinical biochemistry.

[59]  K. Ryder,et al.  Incidence and Amount of Turbidity, Hemolysis, and Icterus in Serum From Outpatients , 1991 .

[60]  H. Worth,et al.  Pseudohypophosphataemia as a Result of Bilirubin Interference , 1990, Annals of clinical biochemistry.

[61]  D. Blank,et al.  A model for assessing interference. , 1987, Clinical chemistry.

[62]  A. Wu,et al.  Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays, and the effect of ferrocyanide. , 1986, Clinical chemistry.

[63]  T. Nakahara,et al.  Mechanical effects on rates of hemolysis. , 1986, Journal of biomedical materials research.

[64]  J. Ladenson,et al.  Analytical Errors due to Lipemia , 1983 .

[65]  C. Schauf,et al.  Mechanical fragility of erythrocytes in multiple sclerosis , 1980, Neurology.

[66]  P. Li,et al.  Mechanism of interference by hemoglobin in the determination of total bilirubin. I. Method of Malloy-Evelyn. , 1980, Clinical chemistry.

[67]  L. Sklar,et al.  Human serum albumin. Spectroscopic studies of binding and proximity relationships for fatty acids and bilirubin. , 1979, The Journal of biological chemistry.

[68]  P. Winkel,et al.  Factors contributing to intra-individual variation of serum constituents: 4. Effects of posture and tourniquet application on variation of serum constituents in healthy subjects. , 1974, Clinical chemistry.

[69]  A C BURTON,et al.  MECHANICAL PROPERTIES OF THE RED CELL MEMBRANE. I. MEMBRANE STIFFNESS AND INTRACELLULAR PRESSURE. , 1964, Biophysical journal.

[70]  Optical techniques , 2022, Physics Subject Headings (PhySH).